The Newest Addition to the World’s #1 Chosen Filler Collection is Now FDA Approved!

To say that Allergan Aesthetics is one of the most innovative aesthetics developers and manufacturers feels like an understatement. After bringing us products like Botox, the most popular anti-aging wrinkle treatment in the world, and Latisse, the only FDA-approved eyelashes treatment for longer, fuller, darker lashes – Allergan has done it again!

We are so excited to introduce JUVÉDERM VOLUX XC, the first and only hyaluronic acid (HA) filler approved by the FDA for the improvement in jawline definition!

Artemedica Honored as FDA Clinical Study Site

Artemedica was one of 19 FDA clinical study sites in the United States! Both Artemedica physicians, Dr. Victor Lacombe and Dr. Alice Chiang were clinical investigators in the study and successfully treated study participants with over 100 syringes of JUVÉDERM VOLUX XC.

This means Artemedica will be one of the first practices in the nation to offer JUVÉDERM VOLUX XC, well before it becomes commercially available!

What is JUVÉDERM VOLUX XC?

VOLUX XC is the newest addition to the JUVÉDERM collection, the world’s #1 chosen line of facial fillers! JUVÉDERM VOLUX XC is the first and only FDA-approved HA filler for jawline definition. 

Clinical Study Results

During the clinical study, participants reported high satisfaction with their VOLUX XC treatment results. In fact, at the 6-month post-treatment check-in, 89.7% of patients reported they would recommend JUVÉDERM VOLUX XC to a friend. After 12 months, 87.2% of participants reported they were satisfied with their results and would recommend the treatment.

Possible Side Effects

The possible side effects reported during the clinical study usually subsided after 2 weeks and were consistent with typical HA injections. Mild to moderate tenderness, swelling, firmness, redness, itching, discoloration, and bruising at the injection sites were the most commonly reported side effects.

When Will JUVÉDERM VOLUX XC Be Available?

Artemedica will begin offering JUVÉDERM VOLUX XC injectables as early as Fall 2022! Both our Santa Rosa and Healdsburg offices are looking forward to treating women and men in Sonoma, Napa, Marin, and surrounding counties. 

If you want to be one of the first patients in the nation to experience JUVÉDERM VOLUX XC jawline filler treatments, please fill out the form below to be placed on our treatment waiting list! 

JUVÉDERM VOLUX XC WAITING LIST